Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression-Reference-Cited by-同舟云学术

Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression

Published:2009-10 Issue:10 Volume:68 Page:1073-1083
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:J Neuropathol Exp Neurol

Author:

Song Yun Ju C.,Halliday Glenda M.,Holton Janice L.,Lashley Tammaryn,O'Sullivan Seán S.,McCann Heather,Lees Andrew J.,Ozawa Tetsutaro,Williams David R.,Lockhart Paul J.,Revesz Tamas R.

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Neurology,General Medicine,Pathology and Forensic Medicine

Reference62 articles.

1. Neuroinflammatory processes in Parkinson's disease

2. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

3. The role of glial cells in Parkinsonʼs disease

4. Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease

5. NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis;Experimental Neurology;2024-09

2. Astrocyte-derived apolipoprotein D is required for neuronal survival in Parkinson’s disease;npj Parkinson's Disease;2024-08-02

3. Reanalysis of DIA Data Demonstrates the Capabilities of MS/MS-Free Proteomics to Reveal New Biological Insights in Disease-Related Samples;Journal of the American Society for Mass Spectrometry;2024-06-28

4. MUFA synthesis and stearoyl-CoA desaturase as a new pharmacological target for modulation of lipid and alpha-synuclein interaction against Parkinson's disease synucleinopathy;Neuropharmacology;2024-05

5. Reanalysis of Orbitrap Astral DIA data demonstrates the capabilities of MS/MS-free proteomics to reveal new biological insights in disease-related samples;2024-04-01